Skip to the main content
The Crier

NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025

NHS EnglandYorkshire and The Humbergoodsabove thresholdFramework
Your saved contracts

What the buyer wrote

NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 Offer reference number: CM/PHS/25/5728 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/PHS/25/5728/01 - National Framework for Medical Retinal Vascular Treatments: 7NAT (National) 01/12/2025 to 31/05/2027 (18 months) CM/PHS/25/5728/02 - Regional Framework for Medical Retinal Vascular Treatments aflibercept 2mg: NOFE: (North of England) 01/12/2025 to 31/05/2027 (18 months) SOFE: (South of England) 01/12/2025 to 31/05/2027 (18 months) MAE: (Mi…

Read all of it on Find a Tender →

Bid for this and lost? There is a short window in which the decision can be questioned.

Awarded to

Abbvie Ltd£688.8mends (31 May 2027)

Details

What the buyer calls it
NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025
How they are buying
Advertised, open to anyoneAny supplier could bid without being invited first.
Type
goods
Framework
Yes: joining it lets you bid for call-offs without a new tender each time
Work starts
1 Dec 2025
Work ends
31 May 2027
Where
in Yorkshire and The Humber, in London

Who the buyer named

The buyer published a contact address on this notice. Questions closed on 7 Jul 2025, 13:00 BST.

david.ford1@nhs.net